MyriaMeat Achieves First-Ever Functional Muscle Contractions in Cultivated Pork

MyriaMeat, a cultivated meat start-up based in Munich, has achieved a significant milestone by developing pig muscle tissue from pluripotent stem cells that exhibits functional muscle contractions. This breakthrough represents the first time that cultivated pork has demonstrated the ability of real muscle tissue, bringing lab-grown meat closer to conventionally farmed pork. The company aims to position cultivated meat as a direct alternative rather than a substitute by mirroring the structural and functional properties of conventional meat, which could increase acceptance among consumers.

Founded as a spin-off from a research team at the University of Göttingen, MyriaMeat is led by CEO Florian Hüttner and chief scientific officer Dr. Malte Tiburcy, who are focused on creating a sustainable alternative to traditional meat production using stem cells. The company's innovation in generating functional muscle tissue from pluripotent stem cells could pave the way for producing cultivated pork at scale, positioning itself as a strategic partner for integrating cultivated meat into existing supply chains. MyriaMeat also emphasizes the safety benefits of cultivated meat, highlighting its potential to reduce the risk of disease transmission compared to traditional animal farming.